financetom
Business
financetom
/
Business
/
Titan Q1FY22 preview: Street expects revenue growth of 52.5%
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Titan Q1FY22 preview: Street expects revenue growth of 52.5%
Aug 4, 2021 6:07 AM

Titan will report its Q1FY22 earnings numbers on August 4. For the company, the big trigger is to unlock more than the numbers because it has given a Q1FY22 update already. The stock at 67 times FY23 earnings does not have much room for disappointment.

The company has recorded revenue growth of 117 percent excluding bullion sales of Q1FY22 and revenue excluding it would be close to around Rs 2,715 crore. Importantly it would be decline of 62 percent on a quarter-on-quarter (QoQ) basis. On a year-on-year (YoY) basis the street is working with a number of Rs 2,835 crore, a jump of 52.5 percent.

The EBITDA is expected to be around Rs 135 crore versus the loss of Rs 246 crore same time last year. Margins are seen at 4.8 percent.

Watch accompanying video of CNBC-TV18’s Mangalam Maloo listing out the key expectations.

(Edited by : Abhishek Jha)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ElevenLabs staff to sell shares at $6.6 billion valuation, Bloomberg News reports
ElevenLabs staff to sell shares at $6.6 billion valuation, Bloomberg News reports
Sep 8, 2025
(Reuters) -ElevenLabs is letting employees sell shares at a valuation of $6.6 billion - double the voice cloning artificial intelligence startup's previous value, Bloomberg News reported on Monday. ElevenLabs had raised $180 million in its last funding round in January which gave it a valuation of $3.3 billion at the time. AI startups engaged in a fierce competition for talent...
Boston Scientific Outperforming MedTech Sector Driven by Electophysiology Business, Oppenheimer Says
Boston Scientific Outperforming MedTech Sector Driven by Electophysiology Business, Oppenheimer Says
Sep 8, 2025
10:47 AM EDT, 09/08/2025 (MT Newswires) -- Boston Scientific ( BSX ) is outperforming the medical technology sector, with growth over the past year driven by its electophysiology business, Oppenheimer said in a Monday note. BSX represents one of the best large-cap medtech growth stories, driven by disciplined mergers and acquisitions and strong execution, most obviously in the [electophysiology] franchise,...
Nike's Frenemies Just Locked Arms - And They're Coming For Control
Nike's Frenemies Just Locked Arms - And They're Coming For Control
Sep 8, 2025
In a landmark $2.4 billion deal, Dick’s Sporting Goods Inc has officially acquired Foot Locker Inc ( FL ) , creating a retail powerhouse with over 3,200 stores across 20 countries. The merger positions the combined entity as a formidable force in the athletic retail industry. It also has some significant implications for Nike Inc ( NKE ) . Track...
Miami International Rides Tech Edge To $345 Million IPO: Analysts See Upside In Options Overhaul
Miami International Rides Tech Edge To $345 Million IPO: Analysts See Upside In Options Overhaul
Sep 8, 2025
Miami International Holdings Inc ( MIAX ) raised $345 million in its U.S. initial public offering in mid-August. Here are some analysts who began coverage of the stock. Rosenblatt Securities analyst Chris Brendler initiated coverage with a Buy rating and price target of $50. JPMorgan analyst Kenneth Worthington began coverage with a Neutral rating and a price target of $32....
Copyright 2023-2026 - www.financetom.com All Rights Reserved